Review



rabbit anti-human her2 (clone sp3)  (Fisher Scientific)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Fisher Scientific rabbit anti-human her2 (clone sp3)
    Rabbit Anti Human Her2 (Clone Sp3), supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-human+her2+(clone+sp3)/bt474+her2++breast+cancer+cells/pm24035511-59-0-22
    Average 90 stars, based on 1 article reviews
    rabbit anti-human her2 (clone sp3) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients.
    Article Snippet: Rabbit anti-human HER2 (clone SP3), Tris-EDTA buffer ( 100 magnification), and Tris-buffered saline with Tween 20 buffer ( 20 magnification) were from Fisher Scientific (Pittsburgh, PA).



    Similar Products

    rabbit anti-human her2 clone sp3  (Spring Bioscience)
    90
    Spring Bioscience rabbit anti-human her2 clone sp3
    Illustration of the proposed multifunctional <t>anti-HER2</t> gold nanoshell with HER2 receptor targeting and photothermal therapy
    Rabbit Anti Human Her2 Clone Sp3, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-human+her2+(clone+sp3)/anti+her2+sp3+rabbit+monoclonal+antibody/pmc06626398-89-15-22
    Average 90 stars, based on 1 article reviews
    rabbit anti-human her2 clone sp3 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    rabbit anti-human her2 (clone sp3)  (Fisher Scientific)
    90
    Fisher Scientific rabbit anti-human her2 (clone sp3)
    Illustration of the proposed multifunctional <t>anti-HER2</t> gold nanoshell with HER2 receptor targeting and photothermal therapy
    Rabbit Anti Human Her2 (Clone Sp3), supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-human+her2+(clone+sp3)/bt474+her2++breast+cancer+cells/pm24035511-59-0-22
    Average 90 stars, based on 1 article reviews
    rabbit anti-human her2 (clone sp3) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Illustration of the proposed multifunctional anti-HER2 gold nanoshell with HER2 receptor targeting and photothermal therapy

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer

    doi: 10.1186/s13046-019-1305-x

    Figure Lengend Snippet: Illustration of the proposed multifunctional anti-HER2 gold nanoshell with HER2 receptor targeting and photothermal therapy

    Article Snippet: HER2 expression was assessed on 5 μm-thick paraffin sections with an indirect immunoperoxydase method using rabbit anti-Human HER2 (dilution 1:100, clone SP3, Spring Bioscience) as the primary monoclonal antibody.

    Techniques:

    a Diagram showing steps in anti-HER2 gold nanoshell (GN) synthesis with corresponding TEM images. b UV-Vis absorption spectra of anti-HER2 GNs. c HER2 gene copy number, mRNA expression and immunostaining (brown) for BT474-R cell line (* P < 0.05). d Immunostaining of BT474-R cells incubated with trastuzumab-FITC (green, left panel). Dark field images of BT474-R cells incubated with anti-HER2 gold nanoshells (right panel)

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer

    doi: 10.1186/s13046-019-1305-x

    Figure Lengend Snippet: a Diagram showing steps in anti-HER2 gold nanoshell (GN) synthesis with corresponding TEM images. b UV-Vis absorption spectra of anti-HER2 GNs. c HER2 gene copy number, mRNA expression and immunostaining (brown) for BT474-R cell line (* P < 0.05). d Immunostaining of BT474-R cells incubated with trastuzumab-FITC (green, left panel). Dark field images of BT474-R cells incubated with anti-HER2 gold nanoshells (right panel)

    Article Snippet: HER2 expression was assessed on 5 μm-thick paraffin sections with an indirect immunoperoxydase method using rabbit anti-Human HER2 (dilution 1:100, clone SP3, Spring Bioscience) as the primary monoclonal antibody.

    Techniques: Expressing, Immunostaining, Incubation

    a Kinetic bio-distribution of anti-HER2 gold nanoshells (GNs) after intravenous administration of 3.5 × 10 13 nanoshells in mice using magnetic resonance imaging (MRI). Results are expressed as percentages of initial signal variations (ΔSI), each signal intensity being compared with a pre-contrast signal. b Absolute gold concentration in blood and tissue samples after intravenous administration of 3.5 × 10 13 anti-HER2 GNs using ICP-MS. Data is expressed as mean ± standard deviation, and comparisons between the liver and spleen concentrations were made using Student’s t-test (* P < 0.05). c Dark field images of tissue sections obtained from the liver and spleen after injection of anti-HER2 GNs. d TEM images of anti-HER2 GNs internalized in liver and spleen cells

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer

    doi: 10.1186/s13046-019-1305-x

    Figure Lengend Snippet: a Kinetic bio-distribution of anti-HER2 gold nanoshells (GNs) after intravenous administration of 3.5 × 10 13 nanoshells in mice using magnetic resonance imaging (MRI). Results are expressed as percentages of initial signal variations (ΔSI), each signal intensity being compared with a pre-contrast signal. b Absolute gold concentration in blood and tissue samples after intravenous administration of 3.5 × 10 13 anti-HER2 GNs using ICP-MS. Data is expressed as mean ± standard deviation, and comparisons between the liver and spleen concentrations were made using Student’s t-test (* P < 0.05). c Dark field images of tissue sections obtained from the liver and spleen after injection of anti-HER2 GNs. d TEM images of anti-HER2 GNs internalized in liver and spleen cells

    Article Snippet: HER2 expression was assessed on 5 μm-thick paraffin sections with an indirect immunoperoxydase method using rabbit anti-Human HER2 (dilution 1:100, clone SP3, Spring Bioscience) as the primary monoclonal antibody.

    Techniques: Magnetic Resonance Imaging, Concentration Assay, Standard Deviation, Injection

    a T2-weighted magnetic resonance imaging of one xenografted tumor (circle) before and 72 h after intravenous administration of 3.5 × 10 13 non-functionalized gold nanoshells (GNs) or anti-HER2 GNs, with corresponding histograms for percentage of signal initial variations (ΔSI). Each signal intensity is compared with a pre-contrast signal. b Absolute gold concentration in xenografted tumor over time after intravenous administration of non-functionalized gold nanoshells (GNs) or of 3.5 × 10 13 anti-HER2 GNs using ICP-MS. Data is expressed as mean ± standard deviation, and comparisons between mice injected with non-functionalized GNs or with anti-HER2 GNs were made using Student’s t-test (* P < 0.05). c Dark field images of tumor sections at 72 h after injection of GNs. d TEM images of tumors at 72 h showing the presence of GNs within the cytoplasm of cancer cells. e Merged dark field images with immunofluorescence staining of human xenografted tumors 72 h after injection of anti-HER2 GNs, using anti-Cytokeratin (red) or anti-CD31 (green) antibodies (T: tumor; V: microvessel)

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer

    doi: 10.1186/s13046-019-1305-x

    Figure Lengend Snippet: a T2-weighted magnetic resonance imaging of one xenografted tumor (circle) before and 72 h after intravenous administration of 3.5 × 10 13 non-functionalized gold nanoshells (GNs) or anti-HER2 GNs, with corresponding histograms for percentage of signal initial variations (ΔSI). Each signal intensity is compared with a pre-contrast signal. b Absolute gold concentration in xenografted tumor over time after intravenous administration of non-functionalized gold nanoshells (GNs) or of 3.5 × 10 13 anti-HER2 GNs using ICP-MS. Data is expressed as mean ± standard deviation, and comparisons between mice injected with non-functionalized GNs or with anti-HER2 GNs were made using Student’s t-test (* P < 0.05). c Dark field images of tumor sections at 72 h after injection of GNs. d TEM images of tumors at 72 h showing the presence of GNs within the cytoplasm of cancer cells. e Merged dark field images with immunofluorescence staining of human xenografted tumors 72 h after injection of anti-HER2 GNs, using anti-Cytokeratin (red) or anti-CD31 (green) antibodies (T: tumor; V: microvessel)

    Article Snippet: HER2 expression was assessed on 5 μm-thick paraffin sections with an indirect immunoperoxydase method using rabbit anti-Human HER2 (dilution 1:100, clone SP3, Spring Bioscience) as the primary monoclonal antibody.

    Techniques: Magnetic Resonance Imaging, Concentration Assay, Standard Deviation, Injection, Immunofluorescence, Staining

    a Human xenografted tumor growth curves using mice grafted with trastuzumab-resistant HER2-overexpressing BT474-R cell lines. For each treatment group (non-irradiated tumors, irradiated tumors after intravenous administration of non-functionalized GNs, and irradiated tumors after intravenous administration of anti-HER2 GNs), 10 xenografted mice are used. Comparisons between the three treatment groups are made using ANOVA (* P < 0.05, *** P < 0.001). b Quantitative comparisons of tumor necrosis (N), cell proliferation, cell apoptosis and microvessel density between irradiated and non-irradiated tumors. Comparisons between groups are made using Student’s t-test (* P < 0.05, ** P < 0.01). c Double immunofluorescence staining of irradiated human xenografted tumor using anti-cleaved-caspase3 and anti-CD31 antibodies (T: tumor; V: microvessel)

    Journal: Journal of Experimental & Clinical Cancer Research : CR

    Article Title: Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer

    doi: 10.1186/s13046-019-1305-x

    Figure Lengend Snippet: a Human xenografted tumor growth curves using mice grafted with trastuzumab-resistant HER2-overexpressing BT474-R cell lines. For each treatment group (non-irradiated tumors, irradiated tumors after intravenous administration of non-functionalized GNs, and irradiated tumors after intravenous administration of anti-HER2 GNs), 10 xenografted mice are used. Comparisons between the three treatment groups are made using ANOVA (* P < 0.05, *** P < 0.001). b Quantitative comparisons of tumor necrosis (N), cell proliferation, cell apoptosis and microvessel density between irradiated and non-irradiated tumors. Comparisons between groups are made using Student’s t-test (* P < 0.05, ** P < 0.01). c Double immunofluorescence staining of irradiated human xenografted tumor using anti-cleaved-caspase3 and anti-CD31 antibodies (T: tumor; V: microvessel)

    Article Snippet: HER2 expression was assessed on 5 μm-thick paraffin sections with an indirect immunoperoxydase method using rabbit anti-Human HER2 (dilution 1:100, clone SP3, Spring Bioscience) as the primary monoclonal antibody.

    Techniques: Irradiation, Double Immunofluorescence Staining